实用肿瘤学杂志 ›› 2012, Vol. 26 ›› Issue (3): 281-284.doi: 10.3969/j.issn.1002-3070.2012.03.021

• 综述 • 上一篇    下一篇

多原发肺癌的再认识

路飞飞, 于雁   

  1. 哈尔滨医科大学附属第三医院内六科(哈尔滨 150081)
  • 收稿日期:2011-11-25 出版日期:2012-06-28 发布日期:2014-12-03
  • 通讯作者: 于雁,E-mail:gpyuyan@163.com
  • 作者简介:路飞飞,女,(1984-),硕士在读,从事呼吸系统肿瘤内科的临床及基础研究

What is multiple primary lung cancer

LU Feifei,YU Yan   

  1. Department of Oncology,The Third Affiliated Hospital of Harbin Medical University,Harbin 150081
  • Received:2011-11-25 Online:2012-06-28 Published:2014-12-03

摘要: 多原发肺癌(multiple primary lung cancer,MPLC)是一种不常见的肺癌,对于多原发肺癌的诊断标准、发病因素、与肺转移癌的鉴别、治疗及长期生存仍存在争议。随着诊断技术的进步和对多原发肺癌认识的提高,多原发肺癌发病率的报道逐渐增多。我们尝试通过回顾多原发肺癌的现况及其最新相关的分子生物标志物加深我们对多原发肺癌的理解。

Abstract: MPLC is an uncommon entity.As regard to multiple primary lung cancers,the problems relating to diagnostic criteria,epidemic factors,distinguishing between multiple primary lung cancers and intrapulmonary metastasis,treatment options and longterm survival are still the subject of debate.Due to the advanced diagnostic technique and better understanding for multiple primary lung cancers(MPLC),the increasing incidence of MPLC has been reported.We tried to further understand MPLC by reviewing the current status and the latest advancement of molecular markers related to MPLC.

中图分类号: